Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Lee

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
NPJ Vaccines|March 15, 2025
A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responsesRaquel Munoz-Moreno, Viola Allaj, Eddie Gadee, et al.
JACC. Clinical Electrophysiology|January 25, 2023
Retrospective Window of Interest Annotation Provides New Insights Into Functional Channels in Ventricular Tachycardia SubstrateJoshua Hawson, Ahmed Al-Kaisey, Robert D Anderson, et al.
JACC. Clinical Electrophysiology|December 15, 2023
Optimal Annotation of Local Activation Time in Ventricular Tachycardia Substrate MappingJoshua Hawson, Robert D Anderson, Souvik K Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2026
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Directed Graph Mapping for Ventricular Tachycardia: A Comparison to Established Mapping TechniquesJoshua Hawson, Enid Van Nieuwenhuyse, Robin Van Den Abeele, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Real-World Treatment Patterns and Survival in Patients with <i>ROS1</i>-Positive Advanced Non-Small Cell Lung Cancer in Canada and EuropeWinson Y Cheung, Adam Lee, Helena Bote de Cabo, et al.
JAMA Internal Medicine|November 24, 2020
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020Kristina L Bajema, Ryan E Wiegand, Kendra Cuffe, et al.
Journal for Immunotherapy of Cancer|February 12, 2024
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trialDavid P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, et al.
Scientific Reports|May 19, 2015
Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never SmokersJin Sung Jang, Adam Lee, Jun Li, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
NPJ Vaccines|March 15, 2025
A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responsesRaquel Munoz-Moreno, Viola Allaj, Eddie Gadee, et al.
JACC. Clinical Electrophysiology|January 25, 2023
Retrospective Window of Interest Annotation Provides New Insights Into Functional Channels in Ventricular Tachycardia SubstrateJoshua Hawson, Ahmed Al-Kaisey, Robert D Anderson, et al.
JACC. Clinical Electrophysiology|December 15, 2023
Optimal Annotation of Local Activation Time in Ventricular Tachycardia Substrate MappingJoshua Hawson, Robert D Anderson, Souvik K Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2026
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743Arnaud Scherpereel, Paul Baas, Anna K Nowak, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Directed Graph Mapping for Ventricular Tachycardia: A Comparison to Established Mapping TechniquesJoshua Hawson, Enid Van Nieuwenhuyse, Robin Van Den Abeele, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Real-World Treatment Patterns and Survival in Patients with <i>ROS1</i>-Positive Advanced Non-Small Cell Lung Cancer in Canada and EuropeWinson Y Cheung, Adam Lee, Helena Bote de Cabo, et al.
JAMA Internal Medicine|November 24, 2020
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020Kristina L Bajema, Ryan E Wiegand, Kendra Cuffe, et al.
Journal for Immunotherapy of Cancer|February 12, 2024
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trialDavid P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, et al.
Scientific Reports|May 19, 2015
Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never SmokersJin Sung Jang, Adam Lee, Jun Li, et al.
Pageof 20